Quick Answer
Silo Pharma, Inc. reported Earnings Per Share Diluted of $0.50 (loss) per share for the year ending 2025.
- Silo Pharma, Inc. showed an increase of +58.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Silo Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2017 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2017 to 2025), Silo Pharma, Inc.'s Earnings Per Share Diluted has declined by 5,100.0%.
- Historical annual values: Fiscal year 2025: $0.50 (loss) per share | Fiscal year 2024: $1.19 (loss) per share | Fiscal year 2023: $1.20 (loss) per share | Fiscal year 2021: $0.04 per share | Fiscal year 2020: $0.05 (loss) per share | Fiscal year 2018: $0.02 (loss) per share | Fiscal year 2017: $0.01 per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: